- Home
- KIRK vs KALA Comparison
KIRK vs KALA Comparison
Compare KIRK & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- KALA
- Stock Information
- Founded
- KIRK 1966
- KALA 2009
- Country
- KIRK United States
- KALA United States
- Employees
- KIRK N/A
- KALA N/A
- Industry
- KIRK Diversified Commercial Services
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- KIRK Miscellaneous
- KALA Health Care
- Exchange
- KIRK Nasdaq
- KALA Nasdaq
- Market Cap
- KIRK 24.0M
- KALA 26.2M
- IPO Year
- KIRK 2002
- KALA 2017
- Fundamental
- Price
- KIRK $1.10
- KALA $5.26
- Analyst Decision
- KIRK Buy
- KALA Strong Buy
- Analyst Count
- KIRK 2
- KALA 3
- Target Price
- KIRK $4.50
- KALA $14.00
- AVG Volume (30 Days)
- KIRK 261.5K
- KALA 64.7K
- Earning Date
- KIRK 06-17-2025
- KALA 08-05-2025
- Dividend Yield
- KIRK N/A
- KALA N/A
- EPS Growth
- KIRK N/A
- KALA N/A
- EPS
- KIRK N/A
- KALA N/A
- Revenue
- KIRK $431,111,000.00
- KALA N/A
- Revenue This Year
- KIRK N/A
- KALA N/A
- Revenue Next Year
- KIRK N/A
- KALA N/A
- P/E Ratio
- KIRK N/A
- KALA N/A
- Revenue Growth
- KIRK N/A
- KALA N/A
- 52 Week Low
- KIRK $1.05
- KALA $2.92
- 52 Week High
- KIRK $2.50
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- KIRK 45.02
- KALA 68.75
- Support Level
- KIRK $1.05
- KALA $3.82
- Resistance Level
- KIRK $1.28
- KALA $4.41
- Average True Range (ATR)
- KIRK 0.06
- KALA 0.42
- MACD
- KIRK -0.01
- KALA 0.07
- Stochastic Oscillator
- KIRK 18.52
- KALA 92.00
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.